Number of data sets included | HR (95% CI) | I2 (%) | p Value | |
---|---|---|---|---|
Overall | 54 | 0.83 (0.79 to 0.87) | 65.6 | <0.001 |
Sex | ||||
Male | 22 | 0.83 (0.75 to 0.92) | 71.0 | <0.001 |
Female | 14 | 0.83 (0.73 to 0.94) | 67.9 | <0.001 |
Study location | ||||
North America | 11 | 0.83 (0.74 to 0.93) | 80.5 | <0.001 |
Europe | 24 | 0.82 (0.75 to 0.90) | 69.3 | <0.001 |
Asia | 19 | 0.81 (0.76 to 0.85) | 0.0 | 0.462 |
Duration of follow-up (year) | ||||
<10 | 23 | 0.83 (0.76 to 0.92) | 62.6 | <0.001 |
≥10 | 29 | 0.84 (0.79 to 0.89) | 66.2 | <0.001 |
Cancer types | ||||
Colorectal cancer | 6 | 0.79 (0.71 to 0.88) | 0.00 | 0.477 |
p Value of Q-test for heterogeneity test.